IGF2 and intrahepatic cholangiocarcinoma: The association between lower methylation at the IGF2 intron 3 region and ICC risk remained essentially unchanged (OR 1.88, 95 % CI 1.10–3.33) when restricting analysis to women aged 30+ years.